Subscribe To
Context therapeutics prepares for a busy 2022 as it advances women's oncology treatments
If 2021 was a pivotal year for Context Therapeutics (NASDAQ:CNTX) Inc, 2022 promises to be even more so. Fresh from a US$31.25 million fundraise and...
February 23, 2022, 6:31 am
Context therapeutics prepares for a busy 2022 as it advances women's oncology treatments
If 2021 was a pivotal year for Context Therapeutics (NASDAQ:CNTX) Inc, 2022 promises to be even more so. Fresh from a US$31.25 million fundraise and...
February 23, 2022, 6:31 am
Sigyn therapeutics to present at the bullseye small cap virtual investor conference
SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:...
January 25, 2022, 8:00 am
Sigyn therapeutics to present at the bullseye small cap virtual investor conference
SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:...
January 25, 2022, 8:00 am
Sigyn therapeutics to present at the bullseye small cap virtual investor conference
SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:...
January 25, 2022, 8:00 am
Is progyny a good buy opportunity at the current share price?
Progyny, Inc (NASDAQ: PGNY) shares have weakened more than 20% since November 05, even though the compa...
December 27, 2021, 1:43 pm
Is progyny a good buy opportunity at the current share price?
Progyny, Inc (NASDAQ: PGNY) shares have weakened more than 20% since November 05, even though the compa...
December 27, 2021, 1:43 pm
Is progyny a good buy opportunity at the current share price?
Progyny, Inc (NASDAQ: PGNY) shares have weakened more than 20% since November 05, even though the compa...
December 27, 2021, 1:43 pm